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The use of partial 16S rDNA sequencing (first one-third of the gene) for the identification of 
Mycobacterium species from cultured isolates has become recognized as a very accurate 
method for identification. The distinction between M. chelonae and M. abscessus, however, 
is not possible with partial 16S rDNA sequencing and therefore requires additional testing. 
Conventional tests that have been used for the distinction include growth on 5% sodium 
chloride and growth on citrate medium, both of which have been problematic with test 
inaccuracies and prolonged turnaround time. Restriction analysis of an amplified fragment 
of the hsp65 gene can distinguish M. chelonae from M. abscessus, but this requires gel 
analysis and interpretation of fragment sizes and is sometimes difficult because of the 
similarity of restriction patterns. In this study we developed a simple and rapid method 
using real-time PCR with the SmartCycler™ (Cepheid, Sunnyvale, CA) to distinguish M. 
abscessus and M. chelonae. The PCR assay is designed with 1 set of primers targeting a 
small portion of the 16S-23S ITS region and 2 separately labeled MGB Eclipse™ probes 
(Nanogen, Inc., Bothell, WA); 1 specific for M. chelonae and 1 specific for M. abscessus. We 
compared the PCR results of 50 isolates (25 M. chelonae and 25 M. abscessus) with results 
obtained using restriction patterns of the hsp65 gene and showed 100% agreement. 
Additionally we performed PCR, in a blinded fashion, on 90 routine isolates submitted for 
16S rDNA sequencing for identification. The samples included 26 isolates of M. chelonae-M. 
abscessus complex and 64 remaining isolates including Mycobacterium species, Nocardia 
species, other actinomycetes and culture contaminants (Staphylococcus epidermidis, 
Microbacterium species). Specificity and sensitivity were both 100% using the PCR assay 
compared to 16S rDNA sequencing. The described PCR assay using MGB Eclipse™ Probes 
is very accurate and specific, is easy to perform, and is a good supplemental test when using 
16S rDNA sequencing for the identification of Mycobacterium sp.
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CONTACT
Design of Primers and Probes  
	 - Obtained sequences from the 16S-23S ITS region  
	 - Sequences aligned (Lasergene® v6.0, DNASTAR, Inc., Madison, WI) 
	 - Conserved regions for primers determined
	 - Variable regions for probes determined 
	 - Custom oligonucleotides selected for the MGB Eclipse™ Probe System (Table 1)  
MGB Eclipse™ Probe System
	 - MGB  Eclipse™ Design Software (Nanogen, Inc., Bothell, WA).  
	 - Primer mix:  
	 	 forward primer (5'-CATTTCCCAGTCGAATGAACT) 
	 	 reverse primer (5'-CAGG[A*]TTTA[A*]AAA[A*]CAT[A*]TTCACCAAG)   	
	 - Probe mix:
	 	 M. chelonae probe (TET (5'-AG[N*]G[A*]GTTTC[T*]GT[A*]G[T*]GG)  
	 	 M. abscessus probe (FAM (5'-AGTAGGCATCTGTAGTGG)
 
	 [A*] designating a proprietary modified base, Super A™  
	 [N*] designating a universal proprietary modified base, Super N™ 
	 [T*] designating proprietary modified bases Super T™ 
DNA Extraction 
DNA was extracted from isolated bacterial organisms using the PrepMan Ultra 
reagent (Applied Biosystems, Foster City, CA) according to the manufacturer's 
instructions.
PCR
 The PCR master mix was prepared according to Table 2 using OmniMix® beads 
(Cepheid, Sunnyvale, CA). PCR amplification was performed using the 
SmartCycler™ (Cepheid, Sunnyvale, CA) with the parameters described in Table 3.
Validation
25 M. chelonae and 25 M. abscessus were identified by PCR-restriction analysis (PRA) 
of a 441 bp (Telenti) fragment of the hsp65 according to Telenti et al. (1993, J. Clin. 
Microbiol. 31:175-178). The ability of the assay to differentiate between M. chelonae 
and M. abscessus was evaluated by testing these 50 species in a blinded fashion. 
PCR specificity was determined by testing 90 consecutive samples of bacteria, 
identified by partial 16S rDNA sequencing (Table 4).  
Table 1.  Probe sequences showing positions of ambiguity among various strains of 
M. chelonae and M. abscessus.   
Species Source Probe Target Sequence 
PCR Probe M. chelonae Current Assay AGNGAGTTTCTGTAGTGG 
M. chelonae  ATCC 35752T AGCGAGTTTCTGTAGTGG 




M. chelonae GenBank AJ291584 AGCGAGTATCTGTAGTGG 
PCR Probe M. abscessus Current Assay AGTAGGCATCTGTAGTGG 
M. abscessus ATCC 19977T AGTAGGCATCTGTAGTGG 




Table 2.  PCR Master Mix.
Omni-Mix Beads 1 bead (2 samples) Final Conc.
Water 27 ul
Mg++ 0 4 mM
Primer Mix (5 uM ea) 10 ul 1.0 uM
FAM Probe (4 uM) 2.5 ul 0.2 uM
TET Probe (4 uM) 2.5 ul 0.2 uM
DNA sample:  4 ul
Table 3.  PCR Amplification Protocol. 
Initial 95C – 120 sec 
42 Cycles 95C – 20 sec 
 55C – 20 sec 
 76C – 20 sec 




Sequence identification confirmed by colony morphology and pigmentation studies. 
b 
Matching sequence retrieved from GenBank.
Table 4.  Validation of MCAC PCR assay:  comparison with partial (5’)  
16S rDNA sequencing. 
Partial 16S rDNA Identification 
No. 
tested MCAC PCR 
M. chelonae-M. abscessus 22 Pos-M. abscessus 
M. chelonae-M. abscessus 4 Pos-M. chelonae 
M. branderi 1 Neg 
M. fortuitum Complex (sqv I)  1 Neg 
M. fortuitum Complex (sqv II)  1 Neg 
M. fortuitum Complex (sqv III)  4 Neg 
M. fortuitum Complex (sqv IV)  1 Neg 
M. goodii 1 Neg 
M. gordonae (sqv I) 9 Neg 
M. gordonae (sqv II) 1 Neg 
M. gordonae (sqv III) 1 Neg 
M. gordonae (sqv V) 2 Neg 
M. immunogenum 1 Neg 
M. intracellulare 3 Neg 
M. kansasii 
a
 1 Neg 
M. kansasii (sqv III or VI-2) 1 Neg 
M. kubicae 2 Neg 
M. lentiflavum  2 Neg 
M. marinum 
a
 3 Neg 
M. mucogenicum 3 Neg 
M. neoaurum 1 Neg 
"M. paraffinicum” 1 Neg 
M. parascrofulaceum 1 Neg 
M. shimoidei 1 Neg 
M. simiae 3 Neg 
M. szulgai 1 Neg 
M. terrae 1 Neg 
M. terrae Complex (MCRO6 
b
) 1 Neg 
M. triplex 1 Neg 
M. xenopi  2 Neg 
"M. lacticola" 2 Neg 
Microbacterium species 1 Neg 
Nocardia asteroides (Drug group IV) 1 Neg 
Nocardia cyriacigeorgica 1 Neg 
Nocardia transvalensis 1 Neg 
Nocardia cyriacigeorgica 1 Neg 
Nocardia farcinica 1 Neg 
Nocardia veterana 1 Neg 
Arcobacter butzleri 1 Neg 
Gordonia bronchialis 1 Neg 
Rhodococcus sp. 1 Neg 
Staphylococcus epidermidis 1 Neg 
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Mean ± 2 Std. Dev.
M. abscessus 28.65 ± 0.692
M. chelonae 34.79 ± 0.557
Within Run Precision
Crossreactivity
The MCAC SmartCycler™ PCR assay described was 
designed for use in the microbiology laboratory as a 
component of the culture algorithm for the identification 
of Mycobacterium species.
The MGB Eclipse™ Probe Systems proved to be an 
acceptable design of the assay and performed well using 
the SmartCycler instrument.  
The described PCR assay is accurate and specific, is easy 
to perform, and is a good supplemental test when using 
16S rDNA sequencing for the identification of 
Mycobacterium species.
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M. CAC PCR using the 
SmartCycler.  Solid 
lines are M. abscessus 
and slashed lines are M. 
chelonae.  Vertical red 
lines show the relative 
crossing threshold.
Crossreactivity of the 
M. CAC PCR assay.  
The solid line is the 
positive control for M. 
abscessus and the 
slashed line is the 
positive control for M. 
chelonae.
Realtime PCR allows 
for the use of Levy-
Jennings plots to 
evaluate between-run 
precision using day-
to-day quality control 
(QC).  The Crossing 
Threshold (Ct) values 
of daily QC are 
plotted.  The mean 
and standard 
deviation are 
calculated from the 
Ct values.
Within run precision was 
evaluated by calculating 
the mean and standard 
deviation of the Crossing 
Threshold (Ct) values 
generated by each sample 
in the run.  Fi ve 
replicates each of the M. 
abscessus and M. 
chelonae controls were 
used for the evaluation. 
100% accuracy was achieved for the differentiation of M. 
abscessus and M. chelonae using PCR compared to hsp65 
PRA. 
100% sensitivity and 100% specificity were obtaind for the 
detection of M. chelonae-M. abscessus complex using PCR 























M. chelonae (TET probe)









T - type strain
